In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
In this podcast, James Matera, DO, speaks about a patient case presentation of a 41-year-old man with a recurrence of minimal change disease and an incidental finding of papillary renal cell carcinoma on...
In this podcast, Anil Harrison, MD, and Paul Shiu, DO, discuss how to evaluate a patient with newly diagnosed hypertension, pharmacological and non-pharmacological interventions available for patients...
In this episode, Anil Harrison, MD, speaks with Paul Shiu, DO, about a patient with metabolic alkalosis, including the criteria, the most common causes, and the phases of metabolic alkalosis.
In part 1 of this 2-part episode, James Matera, DO, FACOI, speaks about the role, benefits, and challenges of urgent-start peritoneal dialysis in adults and children with chronic kidney disease...
In this video, James Matera, DO, speaks with nephrologist Wayne Kotzker, MD, primary care physician, Maria Ciminelli, MD, cardiologist Lance Berger, MD, and nutritionist Jamie Miller, RD, about the role of...
In this video, James Matera, DO, discusses a case presentation of a 12-year-old patient with nephropathic cystinosis, including the diagnosis, management, follow-up, and ways to coordinate with the care...
In this podcast, James Matera, DO, speaks about the importance and benefits of urgent-start peritoneal dialysis (PD) in the management of patients with chronic kidney disease, the tools needed for a...
In this video, James Matera, DO, discusses hyperuricemia vs gout, recent studies on the role of lubricin in patients with gout, and a case presentation of a 76-year-old woman with significant hyperuricemia,...
